During the past decade, Fakultni Nemocnice Ostrava, Kozni oddeleni conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Fakultni Nemocnice Ostrava, Kozni oddeleni" #1 collaborator was "Bristol-Myers Squibb" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Fakultni Nemocnice Ostrava, Kozni oddeleni" are "Dermatitis, Atopic" (2 trials), "Progressive Brain Metastasis" (1 trials) and "Unresectable or Metastatic Melanoma" (1 trials). Many other conditions were trialed in "Fakultni Nemocnice Ostrava, Kozni oddeleni" in a lesser frequency.

Most popular intervention types in "Fakultni Nemocnice Ostrava, Kozni oddeleni" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Abrocitinib 100 mg" (1 trials), "Abrocitinib 200 mg" (1 trials), "HBI-8000 in combination with nivolumab" (1 trials) and "PF-04965842 100 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Fakultni Nemocnice Ostrava, Kozni oddeleni" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Fakultni Nemocnice Ostrava, Kozni oddeleni". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Fakultni Nemocnice Ostrava, Kozni oddeleni, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Fakultni Nemocnice Ostrava, Kozni oddeleni, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".